IDXX NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

IDEXX Laboratories Inc · Healthcare · Diagnostics & Research

Open interactive chart View report data
Latest close 544.3 USD
-4.1% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -8.7% below the Trend Line and sits at 10.2% of its 52-week range. The latest completed week returned -4.1%, after a -1.3% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is mixed with 28/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal; earnings are due in 2d.

Setup score 32 out of 100
Latest Close 544.3 USD 24 Jul 2026
1W Return -4.1% latest completed week
4W Return -1.3% short-term follow-through
12W Return -4.1% quarterly tape
Trend Breadth 53.8% 28 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -4.1% Latest completed week; four-week move -1.3%. Indicator stack 30/61 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Mixed 28/100 conviction; expected move 10.8%. News sentiment 55/100 47 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -8.7% below the Trend Line and sits at 10.2% of its 52-week range. The latest completed week returned -4.1%, after a -1.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1412-week average 0.06

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.14Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -1.3% over four weeks, -4.1% over 12 weeks, and -3.7% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-4.1%
4W-1.3%
12W-4.1%
26W-21.6%
52W-3.7%
Active trend streak0 weeks
Active weeks in one year28
Trend breadth53.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.34Latest activity-pressure read.
Pressure change60.2%Four-week change in activity pressure.
Leadership-20.51Latest relative-leadership reading.
RS change11.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength15/100Blend of value, momentum, and quality. Underlying universe rank 86; rank 1 is best.
Value3/100Relative valuation strength. Underlying universe rank 98; rank 1 is best.
Quality99/100Profitability and accounting quality. Underlying universe rank 2; rank 1 is best.
Momentum24/100Medium-term price momentum. Underlying universe rank 77; rank 1 is best.
Growth82/100Revenue and earnings growth. Underlying universe rank 19; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
39.2x
Price divided by trailing earnings.
Price / sales
9.7x
Market value relative to trailing revenue.
EV / EBITDA
28.1x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
3.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
62.1%
Gross profit retained from each unit of revenue.
Operating margin
31.7%
Operating profit retained from revenue.
Free-cash-flow margin
30.0%
Free cash flow generated from revenue.
Return on invested capital
45.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
13.1%
Latest one-year revenue growth.
EPS growth
22.4%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
21.3%
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
2.5%
Net share repurchases relative to market value.
Shareholder yield
2.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

IDXX shows mixed options pressure with a 28/100 conviction score, put-call volume ratio of 1.00, expected move of 10.8%, and Sharemaestro trend signal inactive.

Conviction28/100
Expected move10.8%
Put/call volume1.00
Pressure5
Speculation16
Volatility77
Trend agreement55
Open options detail
Insider activity18 / 2

18 acquisitions and 2 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment55/100

Weighted news tone is neutral across 47 relevant articles.

18 positive · 26 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
Options expected move10.8%Nearest-chain priced movement where available.
52-week drawdown-29.3%Distance below the 52-week high.
13-week volatility2.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+5.8%Week of 22 May.
Worst week-7.4%Week of 6 Mar.
Latest week-4.1%Week of 24 Jul.

Shape of recent returns

Strong gains2
Modest gains10
Flat weeks0
Modest losses10
Sharp losses4
Recent vol2.6%13-week weekly-return volatility.
Base vol4.7%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew3.6% / -2.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape32/100

Trend, activity pressure, participation, and risk combine to a 32/100 tape read.

 Indicator analysis21/100

Latest 12-week confirmation: trend 0/12, activity pressure 6/12, relative leadership 0/12.

Activity pressure 0.14; No reversal markers Factors35/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 21 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options45/100

IDXX shows mixed options pressure with a 28/100 conviction score, put-call volume ratio of 1.00, expected move of 10.8%, and Sharemaestro trend signal inactive.

Mixed · Options-market disagreement · Expected move 10.8% Sentiment55/100

Weighted news tone is neutral across 47 relevant articles.

IDEXX Releases 2025 Corporate Responsibility Report Highlighting Innovation and Sustainability Progress Insiders18 / 2

18 acquisitions and 2 disposals in the latest 180-day insider tape.

 Earnings2d

Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026544.3 USD-4.1%596.1 USD528.6 USD0.34-20.512.2MOff
17 Jul 2026567.4 USD0.7%600.9 USD528.6 USD0.59-18.783.4MOff
10 Jul 2026563.6 USD1.0%605.4 USD528.5 USD0.49-22.843.4MOff
3 Jul 2026557.8 USD1.1%610.1 USD528.4 USD0.29-22.533.0MOff
26 Jun 2026551.5 USD-1.9%615.3 USD528.0 USD0.21-23.043.9MOff
19 Jun 2026562.1 USD0.2%622.0 USD527.7 USD0.05-25.372.9MOff
12 Jun 2026560.9 USD-0.2%627.4 USD527.2 USD-0.17-23.882.5MOff
5 Jun 2026562.2 USD-0.2%631.7 USD526.7 USD-0.34-22.263.3MOff
29 May 2026563.5 USD0.7%636.6 USD526.0 USD-0.58-25.863.1MOff
22 May 2026559.4 USD5.8%638.8 USD525.4 USD-0.80-24.602.9MOff
15 May 2026528.8 USD-5.6%641.5 USD524.8 USD-0.99-28.133.5MOff
8 May 2026560.1 USD-1.3%645.1 USD524.6 USD-1.11-24.483.3MOff
1 May 2026567.5 USD0.3%647.0 USD524.1 USD-1.21-19.613.2MOff
24 Apr 2026565.9 USD-4.0%649.1 USD523.6 USD-1.28-18.772.8MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.